Inhalers for COPD provide steroids ... Inhalers come in three main types: metered-dose inhaler (MDI) dry powder inhaler (DPI) soft mist inhaler (SMI) Keep reading to learn about each type of ...

AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease ... GlaxoSmithKline’s Trelegy is approved in the EU and US, and Chiesi ...

Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease ... and dry powder inhaler (DPI) devices.

GlaxoSmithKline won approval for a three-drug COPD inhaler, Trelegy Ellipta, in 2017. 3D medical animation services have emerged as a groundbreaking tool in the healthcare industry ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...

The FDA has approved an expanded label for GlaxoSmithKline’s new Trelegy Ellipta inhaler, allowing it to be used in a broader population of patients with chronic obstructive pulmonary disease ...

nebulizer therapy may be more affordable than the use of pMDI and DPI devices for many elderly patients with COPD. Medication availability issues and inhaler device convenience features can be key ...